These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
471 related articles for article (PubMed ID: 19856313)
21. Image analyzer-based assessment of tumor-infiltrating T cell subsets and their prognostic values in colorectal carcinomas. Kim Y; Bae JM; Li G; Cho NY; Kang GH PLoS One; 2015; 10(4):e0122183. PubMed ID: 25875774 [TBL] [Abstract][Full Text] [Related]
22. Increased number of forkhead box P3+ tumor-infiltrating lymphocytes correlates with high preoperative albumin level and better survival in patients with stage II or III colorectal cancer. Wang DL; Liu YY; Gu YL; Qin Y; Ji HF; Wu LH; Qi N; Su D; Huang SH; Zhang YQ Tumour Biol; 2015 Jul; 36(7):5407-14. PubMed ID: 25697896 [TBL] [Abstract][Full Text] [Related]
23. Ovarian cancer tumor infiltrating T-regulatory (T(reg)) cells are associated with a metastatic phenotype. Barnett JC; Bean SM; Whitaker RS; Kondoh E; Baba T; Fujii S; Marks JR; Dressman HK; Murphy SK; Berchuck A Gynecol Oncol; 2010 Mar; 116(3):556-62. PubMed ID: 20006900 [TBL] [Abstract][Full Text] [Related]
24. Tumor-infiltrating lymphocytes contain a higher proportion of FOXP3(+) T lymphocytes in cervical cancer. Wu MY; Kuo TY; Ho HN J Formos Med Assoc; 2011 Sep; 110(9):580-6. PubMed ID: 21930068 [TBL] [Abstract][Full Text] [Related]
25. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency. Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837 [TBL] [Abstract][Full Text] [Related]
27. Low expression of Granzyme B in colorectal cancer is associated with signs of early metastastic invasion. Salama P; Phillips M; Platell C; Iacopetta B Histopathology; 2011 Aug; 59(2):207-15. PubMed ID: 21884199 [TBL] [Abstract][Full Text] [Related]
28. Mismatch repair gene defects in sporadic colorectal cancer enhance immune surveillance. Scarpa M; Ruffolo C; Canal F; Scarpa M; Basato S; Erroi F; Fiorot A; Dall'Agnese L; Pozza A; Porzionato A; Castagliuolo I; Dei Tos AP; Bassi N; Castoro C Oncotarget; 2015 Dec; 6(41):43472-82. PubMed ID: 26496037 [TBL] [Abstract][Full Text] [Related]
29. FOXP3+ regulatory T cells in cutaneous T-cell lymphomas: association with disease stage and survival. Gjerdrum LM; Woetmann A; Odum N; Burton CM; Rossen K; Skovgaard GL; Ryder LP; Ralfkiaer E Leukemia; 2007 Dec; 21(12):2512-8. PubMed ID: 17713545 [TBL] [Abstract][Full Text] [Related]
30. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells). Yoshida N; Kinugasa T; Miyoshi H; Sato K; Yuge K; Ohchi T; Fujino S; Shiraiwa S; Katagiri M; Akagi Y; Ohshima K Ann Surg Oncol; 2016 Mar; 23(3):919-27. PubMed ID: 26564244 [TBL] [Abstract][Full Text] [Related]
32. Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers. Kim KJ; Lee KS; Cho HJ; Kim YH; Yang HK; Kim WH; Kang GH Hum Pathol; 2014 Feb; 45(2):285-93. PubMed ID: 24331841 [TBL] [Abstract][Full Text] [Related]
33. Investigations on the clinical significance of FOXP3 protein expression in cervical oesophageal cancer and the number of FOXP3+ tumour-infiltrating lymphocytes. Xia M; Zhao MQ; Wu K; Lin XY; Liu Y; Qin YJ J Int Med Res; 2013 Aug; 41(4):1002-8. PubMed ID: 23760912 [TBL] [Abstract][Full Text] [Related]
34. An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer. Mahmoud SM; Paish EC; Powe DG; Macmillan RD; Lee AH; Ellis IO; Green AR Breast Cancer Res Treat; 2011 May; 127(1):99-108. PubMed ID: 20556505 [TBL] [Abstract][Full Text] [Related]
35. RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1. Burren S; Reche K; Blank A; Galvàn JA; Dawson H; Berger MD; Zlobec I; Lugli A Pathol Res Pract; 2021 Jul; 223():153486. PubMed ID: 34051513 [TBL] [Abstract][Full Text] [Related]
36. CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer. Shinto E; Hase K; Hashiguchi Y; Sekizawa A; Ueno H; Shikina A; Kajiwara Y; Kobayashi H; Ishiguro M; Yamamoto J Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S414-21. PubMed ID: 24566864 [TBL] [Abstract][Full Text] [Related]
37. The role of lymph node size and FOXP3+ regulatory T cells in node-negative colon cancer. Märkl B; Paul B; Schaller T; Kretsinger H; Kriening B; Schenkirsch G J Clin Pathol; 2017 May; 70(5):443-447. PubMed ID: 27879345 [TBL] [Abstract][Full Text] [Related]
38. Low infiltration of peritumoral regulatory T cells predicts worse outcome following resection of colorectal liver metastases. Nakagawa K; Tanaka K; Homma Y; Nojiri K; Kumamoto T; Takeda K; Endo I Ann Surg Oncol; 2015 Jan; 22(1):180-6. PubMed ID: 25120248 [TBL] [Abstract][Full Text] [Related]
39. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer. Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710 [TBL] [Abstract][Full Text] [Related]
40. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer. Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]